Skip Nav Destination
OnlineFirst
Review Article June 24 2022
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Clin Cancer Res clincanres.1129.2022-1-19 13:21:38.193.
Research Article June 23 2022
Classification of BRCA2 variants of uncertain significance (VUS) using an ACMG/AMP model incorporating a homology directed repair (HDR) functional assay
Chunling Hu; Lisa R. Susswein; Maegan E. Roberts; Hana Yang; Megan L. Marshall; Susan Hiraki; Windy Berkofsky-Fessler; Sounak Gupta; Wei Shen; Carolyn A. Dunn; Huaizhi Huang; Jie Na; Susan M. Domchek; Siddhartha Yadav; Alvaro N.A. Monteiro; Eric C. Polley; Steven N. Hart; Kathleen S. Hruska; Fergus J. Couch
Clin Cancer Res clincanres.0203.2022.
Brief Report June 23 2022
Tumor immune microenvironment changes by multiplex immunofluorescence staining in a pilot study of neoadjuvant talazoparib for early-stage breast cancer patients with a hereditary BRCA mutation
Tapsi Kumar; Evthokia Hobbs; Fei Yang; Jeffrey T. Chang; Alejandro Contreras; Edwin R. Parra Cuentas; Haven Garber; Sanghoon Lee; Yiling Lu; Marion E. Scoggins; Beatriz E. Adrada; Gary J. Whitman; Banu K. Arun; Elizabeth A. Mittendorf; Jennifer K. Litton
Clin Cancer Res clincanres.1278.2021.
Article Commentary June 23 2022
Shining a FLASHlight on ultrahigh dose rate radiation and possible late toxicity
Clin Cancer Res clincanres.1255.2022-5-10 22:17:03.080.
Review Article June 23 2022
FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma
Andrea C. Baines; Rachel Ershler; Bindu Kanapuru; Qing Xu; Guoxiang Shen; Liang Li; Lian Ma; Olanrewaju O. Okusanya; Natalie E. Simpson; Wanda Nguyen; Marc R. Theoret; Richard Pazdur; Nicole J. Gormley
Clin Cancer Res clincanres.0618.2022-2-24 13:00:26.277.
Research Article June 23 2022
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study
Deborah M. Stephens; Ying Huang; Amy S. Ruppert; Janek S. Walker; Daniel Canfield; Casey B. Cempre; Qiang Fu; Sharyn Baker; Boyu Hu; Harsh Shah; Renee Vadeboncoeur; Kerry A. Rogers; Seema Bhat; Samantha M. Jaglowski; Hank Lockman; Rosa Lapalombella; John C. Byrd; Jennifer A. Woyach
Clin Cancer Res (2022)
Research Article June 23 2022
Phenotypic Composition of Commercial Anti-CD19 CAR T Cells Affects In Vivo Expansion and Disease Response in Patients with Large B-cell Lymphoma
Chiara Monfrini; Federico Stella; Vanessa Aragona; Martina Magni; Silva Ljevar; Cristina Vella; Eugenio Fardella; Annalisa Chiappella; Francesca Nanetti; Martina Pennisi; Anna Dodero; Anna Guidetti; Paolo Corradini; Cristiana Carniti
Clin Cancer Res (2022)
Research Article June 23 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial
Chung-Han Lee; Robert Motzer; Hamid Emamekhoo; Marc Matrana; Ivor Percent; James J. Hsieh; Arif Hussain; Ulka Vaishampayan; Sandy Liu; Steven McCune; Vijay Patel; Montaser Shaheen; Johanna Bendell; Alice C. Fan; Benjamin A. Gartrell; Oscar B. Goodman, Jr; Petros G. Nikolinakos; Arash Rezazadeh Kalebasty; Yousef Zakharia; Zhentao Zhang; Hema Parmar; Lalith Akella; Keith Orford; Nizar M. Tannir
Clin Cancer Res (2022)
Research Article June 23 2022
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
John D. Martin; Ryan M. Lanning; Vikash P. Chauhan; Margaret R. Martin; Ahmed S. Mousa; Walid S. Kamoun; Hee-Sun Han; Hang Lee; Triantafyllos Stylianopoulos; Moungi G. Bawendi; Dan G. Duda; Edward B. Brown; Timothy P. Padera; Dai Fukumura; Rakesh K. Jain
Clin Cancer Res (2022)
Research Article June 23 2022
SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of Phase I Study
Jifeng Feng; Dihong Tang; Jing Wang; Qi Zhou; Jin Peng; Hanmei Lou; Yuping Sun; Yunlang Cai; Hongmin Chen; Junqin Yang; Pan Liu; Linna Wang; Jianjun Zou
Clin Cancer Res (2022)
Research Article June 23 2022
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study
Massimo Cristofanilli; Hope S. Rugo; Seock-Ah Im; Dennis J. Slamon; Nadia Harbeck; Igor Bondarenko; Norikazu Masuda; Marco Colleoni; Angela DeMichele; Sherene Loi; Hiroji Iwata; Ben O'Leary; Fabrice André; Sibylle Loibl; Eustratios Bananis; Yuan Liu; Xin Huang; Sindy Kim; Maria Jose Lechuga Frean; Nicholas C. Turner
Clin Cancer Res (2022)
Research Article June 23 2022
FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer
Elizabeth S. Duke; Amy K. Barone; Somak Chatterjee; Pallavi S. Mishra-Kalyani; Yuan-Li Shen; Emasenyie Isikwei; Hong Zhao; Youwei Bi; Jiang Liu; Nam Atiqur Rahman; Emily Wearne; John K. Leighton; Maritsa Stephenson; Idara Ojofeitimi; Barbara Scepura; Abhilasha Nair; Richard Pazdur; Julia A. Beaver; Harpreet Singh
Clin Cancer Res (2022)
Research Article June 23 2022
Osimertinib plus Selumetinib in EGFR-Mutated Non–Small Cell Lung Cancer After Progression on EGFR-TKIs: A Phase Ib, Open-Label, Multicenter Trial (TATTON Part B)
James Chih-Hsin Yang; Yuichiro Ohe; Chao-Hua Chiu; Xiaoling Ou; Mireille Cantarini; Pasi A. Jänne; Ryan J. Hartmaier; Myung Ju Ahn
Clin Cancer Res (2022)
Research Article June 23 2022
OLIG2 Is a Determinant for the Relapse of MYC-Amplified Medulloblastoma
Zhenhua Xu; Najiba Murad; Daniel Malawsky; Ran Tao; Samuel Rivero-Hinojosa; Dörthe Holdhof; Ulrich Schüller; Peng Zhang; Christopher Lazarski; Brian R. Rood; Roger Packer; Timothy Gershon; Yanxin Pei
Clin Cancer Res (2022)
Research Article June 23 2022
Phenotype, Function, and Clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma
Xinyi Tang; Zhi-Zhang Yang; Hyo Jin Kim; Theodora Anagnostou; Yue Yu; Xiaosheng Wu; Jun Chen; Jordan E. Krull; Kerstin Wenzl; Patrizia Mondello; Vaishali Bhardwaj; Junwen Wang; Anne J. Novak; Stephen M. Ansell
Clin Cancer Res (2022)
Research Article June 21 2022
Membrane-anchored and tumor-targeted IL-12 (attIL12)-PBMC therapy for osteosarcoma
Qing Yang; Jiemiao Hu; Zhiliang Jia; Qi Wang; Jing Wang; LongHoang Dao; Wendong Zhang; Sheng Zhang; Xueqing Xia; Richard Gorlick; Shulin Li
Clin Cancer Res clincanres.0721.2022-3-6 00:45:30.140.
Brief Report June 21 2022
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B Cell Lymphoma. Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker subanalysis
Natalia Palaz�n-Carri�n; Alejandro Mart�n Garc�a-Sancho; Esteban Nogales-Fern�ndez; Carlos Jim�nez-Cortegana; Fernando Carnicero-Gonz�lez; Eduardo R�os-Herranz; F�tima de la Cruz-Vicente; Guillermo Rodr�guez-Garc�a; Rub�n Fern�ndez-�lvarez; Natividad Mart�nez-Banaclocha; Josep Gum�-Padr�; Jos� G�mez-Codina; Antonio Salar-Silvestre; Delvys Rodr�guez-Abreu; Laura G�lvez-Carvajal; Jorge Labrador; Mar�a Guirado-Risue�o; Daniel J. Garc�a-Dom�nguez; Lourdes Hontecillas-Prieto; Pablo Espejo-Garc�a; Isabel Fern�ndez-Rom�n; Mariano Provencio-Pulla; Margarita S�nchez-Beato; Marta Navarro; Maryl�ne Lejeune; Tom�s s �lvaro-Naranjo; Maria Casanova-Espinosa; V�ctor S�nchez-Margalet; Antonio Rueda-Dom�nguez; Luis de la Cruz-Merino
Clin Cancer Res clincanres.0588.2022-2-21 11:01:45.430.
Research Article June 21 2022
Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Nathaniel Braman; Prateek Prasanna; Kaustav Bera; Mehdi Alilou; Mohammadhadi Khorrami; Patrick Leo; Maryam Etesami; Manasa Vulchi; Paulette Turk; Amit Gupta; Prantesh Jain; Pingfu Fu; Nathan Pennell; Vamsidhar Velcheti; Jame Abraham; Donna Plecha; Anant Madabhushi
Clin Cancer Res clincanres.CCR-21-4148-A.2021.
Research Article June 21 2022
Anti-cancer activity of the combination of cabozantinib and temozolomide in uterine sarcoma
Joseph J. Noh; Young-Jae Cho; Ji-Yoon Ryu; Jung-Joo Choi; Jae Ryoung Hwang; Ju-Yeon Choi; Jeong-Won Lee
Clin Cancer Res clincanres.0985.2022-3-26 05:38:56.960.
Review Article June 21 2022
FDA Approval Summary: Belzutifan for von Hippel-Lindau disease associated tumors
Jaleh Fallah; Michael H. Brave; Chana Weinstock; Gautam U. Mehta; Diana Bradford; Haley Gittleman; Erik W. Bloomquist; Rosane Charlab; Salaheldin S. Hamed; Claudia P. Miller; Sarah E. Dorff; Wiley A. Chambers; Bronwyn D. Mixter; Jeannette Dinin; William F. Pierce; Tiffany K. Ricks; Shenghui Tang; Martha Donoghue; Richard Pazdur; Laleh Amiri-Kordestani; Amna Ibrahim; Julia A. Beaver
Clin Cancer Res clincanres.1054.2022-4-4 11:16:38.037.
Research Article June 21 2022
Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL
Patrick R. Hagner; Hsiling Chiu; Vivek S. Chopra; Martino Colombo; Nisha Patel; Maria Ortiz Estevez; Michelle F. Waldman; Remco Loos; Fadi Towfic; Anita K. Gandhi
Clin Cancer Res (2022)
Research Article June 21 2022
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
Ning Zhao; Shalini Chopra; Kai Trepka; Yung-Hua Wang; Sasank Sakhamuri; Nima Hooshdaran; Hyunjung Kim; Jie Zhou; Shion A. Lim; Kevin K. Leung; Emily A. Egusa; Jun Zhu; Li Zhang; Adam Foye; Renuka Sriram; Emily Chan; Youngho Seo; Felix Y. Feng; Eric J. Small; Jonathan Chou; James A. Wells; Rahul Aggarwal; Michael J. Evans
Clin Cancer Res (2022)
Research Article June 21 2022
VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results
Geoffrey J. Lindeman; Tharu M. Fernando; Rebecca Bowen; Katarzyna J. Jerzak; Xinni Song; Thomas Decker; Frances Boyle; Steve McCune; Anne Armstrong; Catherine Shannon; Gianfilippo Bertelli; Ching-Wei Chang; Rupal Desai; Kushagra Gupta; Timothy R. Wilson; Aulde Flechais; Aditya Bardia
Clin Cancer Res (2022)
Research Article June 21 2022
Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors
Pamela N. Munster; Andrew E. Greenstein; Gini F. Fleming; Erkut Borazanci; Manish R. Sharma; Joseph M. Custodio; Iulia Cristina Tudor; Hristina I. Pashova; Stacie Peacock Shepherd; Andreas Grauer; Jasgit C. Sachdev
Clin Cancer Res (2022)
Research Article June 21 2022
Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
Chang Gon Kim; Nam Suk Sim; Jeong Eun Kim; Kum-Hee Yun; Young Han Lee; Seung Hyun Kim; Wooyeol Baek; Yoon Dae Han; Sang Kyum Kim; Jee Hung Kim; Yoon Woo Koh; Inkyung Jung; Su-Jin Shin; Sun Young Rha; Jin-Hee Ahn; Hyo Song Kim
Clin Cancer Res (2022)
Research Article June 21 2022
EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma
April A. Apfelbaum; Feinan Wu; Allegra G. Hawkins; Brian Magnuson; Jennifer A. Jiménez; Sean D. Taylor; Emma D. Wrenn; Olivia Waltner; Elise R. Pfaltzgraff; Jane Y. Song; Cody Hall; Deneen M. Wellik; Mats Ljungman; Scott N. Furlan; Russell J.H. Ryan; Jay F. Sarthy; Elizabeth R. Lawlor
Clin Cancer Res (2022)
Research Article June 21 2022
Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer
Milan Radovich; Jeffrey P. Solzak; Chao J. Wang; Bradley A. Hancock; Sunil Badve; Sandra K. Althouse; Steven M. Bray; Anna Maria V. Storniolo; Tarah J. Ballinger; Bryan P. Schneider; Kathy D. Miller
Clin Cancer Res (2022)
Research Article June 21 2022
Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases
Clin Cancer Res (2022)
Research Article June 21 2022
Circulating Tumor DNA–Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax
Moritz Fürstenau; Jonathan Weiss; Adam Giza; Fabian Franzen; Sandra Robrecht; Anna-Maria Fink; Kirsten Fischer; Christof Schneider; Eugen Tausch; Stephan Stilgenbauer; Matthias Ritgen; Anke Schilhabel; Monika Brüggemann; Barbara Eichhorst; Michael Hallek; Paula Cramer
Clin Cancer Res (2022)
Research Article June 21 2022
PD-L1 Crosslinking as a New Strategy of 4-1BB Agonism Immunotherapy
Clin Cancer Res (2022)
Research Article June 21 2022
Omission of Upfront Craniospinal Irradiation in Patients with Low-Risk WNT-Pathway Medulloblastoma Is Associated with Unacceptably High Risk of Neuraxial Failure
Tejpal Gupta; Shizan Pervez; Archya Dasgupta; Abhishek Chatterjee; Sridhar Epari; Girish Chinnaswamy; Rakesh Jalali
Clin Cancer Res (2022)
Article Commentary June 21 2022
Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is it all about ME1?
Clin Cancer Res clincanres.1257.2022-5-1 22:00:31.200.
Article Commentary June 21 2022
Combination therapies for advanced hepatocellular carcinoma: biomarkers and unmet needs
Clin Cancer Res clincanres.1213.2022-5-9 09:17:35.930.
Research Article June 17 2022
Circulating tumor DNA (ctDNA) kinetics predict progression-free and overall survival in EGFR TKI-treated patients with EGFR-mutant NSCLC (SWOG S1403)
Philip C. Mack; Jieling Miao; Mary W. Redman; James Moon; Sarah B. Goldberg; Roy S. Herbst; Mary Ann Melnick; Zenta Walther; Fred R. Hirsch; Katerina Politi; Karen Kelly; David R. Gandara
Clin Cancer Res clincanres.CCR-22-0741-A.2022-3-8 14:09:41.447.
Research Article June 17 2022
Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study
Wenjin Yin; Yaohui Wang; Ziping Wu; Yumei Ye; Liheng Zhou; Shuguang Xu; Yanping Lin; Yueyao Du; Tingting Yan; Fan Yang; Jie Zhang; Qiang Liu; Jinsong Lu
Clin Cancer Res clincanres.CCR-22-0446-A.2022-2-9 22:21:43.437.
Research Article June 15 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syndrome in B-Cell ALL Patients Receiving CART19
Caroline Diorio; Rawan Shraim; Regina Myers; Edward M. Behrens; Scott Canna; Hamid Bassiri; Richard Aplenc; Chakkapong Burudpakdee; Fang Chen; Amanda M. DiNofia; Saar Gill; Vanessa Gonzalez; Michele P. Lambert; Allison Barz Leahy; Bruce L. Levine; Robert B. Lindell; Shannon L. Maude; J. Joseph. Melenhorst; Haley Newman; Jessica Perazzelli; Alix E. Seif; Simon F. Lacey; Carl H. June; David M. Barrett; Stephan A. Grupp; David T. Teachey
Clin Cancer Res clincanres.CCR-22-0822-E.2022-3-15 10:15:45.960.
Research Article June 15 2022
Novel DNA Methylation Biomarker Panel for Detection of Esophageal Adenocarcinoma and High-grade Dysplasia
Ming Yu; Helen R. Moinova; Amber Willbanks; Victoria K. Cannon; Ting Wang; Kelly Carter; Andrew Kaz; Deepti Reddi; John Inadomi; Georg Luebeck; Prasad G. Iyer; Marcia I. Canto; Jean S. Wang; Nicholas J. Shaheen; Prashanthi N. Thota; Joseph E. Willis; Thomas LaFramboise; Amitabh Chak; Sanford D. Markowitz; William M. Grady
Clin Cancer Res clincanres.0445.2022-2-11 17:32:55.870.
Research Article June 14 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim; Howard A. Burris; Maria J. de Miguel Luken; Michael J. Pishvaian; Yung-Jue Bang; Michael Gordon; Ahmad Awada; D. Ross. Camidge; F. Stephen. Hodi; Grant A. McArthur; Wilson H. Miller; Andres Cervantes; Laura Q. Chow; Alexander M. Lesokhin; Annemie Rutten; Mario Sznol; Deepali Rishipathak; Shang-Chiung Chen; Eric Stefanich; Tony Pourmohamad; Maria Anderson; Jeong Kim; Mahrukh Huseni; Ina Rhee; Lillian L. Siu
Clin Cancer Res clincanres.4020.2021.
Research Article June 14 2022
Safety and tolerability of MEDI0562, an OX40 agonist monoclonal antibody, in combination with durvalumab or tremelimumab in adult patients with advanced solid tumors
Jonathan W. Goldman; Sarina A. Piha-Paul; Brendan Curti; Katrina S. Pedersen; Todd M. Bauer; Stefanie L. Groenland; Richard D. Carvajal; Vaishali Chhaya; Gray Kirby; Kelly McGlinchey; Scott A. Hammond; Katie L. Streicher; Danielle Townsley; Young Kwang Chae; Jens Voortman; Aurelien Marabelle; John Powderly
Clin Cancer Res clincanres.3016.2021-9-6 10:18:17.230.
Research Article June 13 2022
Multiomic characterisation of high grade serous ovarian carcinoma enables high resolution patient stratification
Robert L. Hollis; Alison M. Meynert; Caroline O. Michie; Tzyvia Rye; Michael Churchman; Amelia Hallas-Potts; Ian Croy; W. Glenn McCluggage; Alistair R.W. Williams; Clare Bartos; Yasushi Iida; Aikou Okamoto; Brian Dougherty; J. Carl Barrett; Ruth March; Athena Matakidou; Patricia Roxburgh; Colin A. Semple; D. Paul Harkin; Richard Kennedy; C. Simon Herrington; Charlie Gourley
Clin Cancer Res clincanres.0368.2022-2-2 06:00:14.580.
Research Article June 13 2022
Assessment of Androgen Receptor splice variant-7 as a biomarker of clinical response in castration-sensitive prostate cancer
Adam G. Sowalsky; Ines Figueiredo; Rosina T. Lis; Ilsa Coleman; Bora Gurel; Denisa Bogdan; Wei Yuan; Joshua W. Russo; John R. Bright; Nichelle C. Whitlock; Shana Y. Trostel; Anson T. Ku; Radhika A. Patel; Lawrence D. True; Jonathan Welti; Juan M. Jimenez-Vacas; Daniel Nava Rodrigues; Ruth Riisnaes; Antje Neeb; Cynthia T. Sprenger; Amanda Swain; Scott Wilkinson; Fatima Karzai; William L. Dahut; Steven P. Balk; Eva Corey; Peter S. Nelson; Michael C. Haffner; Stephen R. Plymate; Johann S. de Bono; Adam Sharp
Clin Cancer Res clincanres.0851.2022-3-16 14:26:47.417.
Research Article June 13 2022
FOXM1 variant contributes to gefitinib resistance via activating wnt/β-catenin signal pathway in non-small cell lung cancer patients
Shaoxing Guan; Xi Chen; Youhao Chen; Wen Xie; Heng Liang; Xia Zhu; Yunpeng Yang; Wenfeng Fang; Yan Huang; Hongyun Zhao; Wei Zhuang; Shu Liu; Min Huang; Xueding Wang; Li Zhang
Clin Cancer Res clincanres.0791.2022-3-11 20:24:57.550.
Research Article June 10 2022
Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a fourth- or later-line therapy
Jian Li; Shirong Cai; Yongjian Zhou; Jun Zhang; Ye Zhou; Hui Cao; Xin Wu; Yanhong Deng; Zhao Huang; Juan Dong; Lin Shen
Clin Cancer Res clincanres.0196.2022-1-20 08:35:31.930.
Review Article June 10 2022
Facts and hopes in the relationship of EBV with cancer immunity and immunotherapy
Clin Cancer Res clincanres.3408.2022-2-28 16:51:58.077.
Research Article June 10 2022
A Randomized Phase II Study of MEDI0680 in Combination with Durvalumab versus Nivolumab Monotherapy in Patients with Advanced or Metastatic Clear-cell Renal Cell Carcinoma
Martin H. Voss; Arun A. Azad; Aaron R. Hansen; Jhanelle E. Gray; Sarah J. Welsh; Xuyang Song; Michael Kuziora; Lina Meinecke; Jorge Blando; Ikbel Achour; Yi Wang; Farzana L. Walcott; Sjoukje F. Oosting
Clin Cancer Res (2022)
Research Article June 10 2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma
Crismita Dmello; Aarón Sonabend; Victor A. Arrieta; Daniel Y. Zhang; Deepak Kanojia; Li Chen; Andrew Gould; Jiangshan Zhang; Seong Jae Kang; Jan Winter; Craig Horbinski; Christina Amidei; Balázs Győrffy; Alex Cordero; Catalina Lee Chang; Brandyn Castro; Patrick Hsu; Atique U. Ahmed; Maciej S. Lesniak; Roger Stupp; Adam M. Sonabend
Clin Cancer Res (2022)
Research Article June 10 2022
Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction
Mojun Zhu; Chunhua Chen; Nathan R. Foster; Christopher Hartley; Taofic Mounajjed; Marcela A. Salomao; Briant F. Fruth; Staci E. Beamer; Yohan Kim; Susan M. Harrington; Henry C. Pitot; Cristobal T. Sanhueza; Yening Feng; Joerg Herrmann; Robert R. McWilliams; Fabrice Lucien; Bing Q. Huang; Wen Wee Ma; Tanios S. Bekaii-Saab; Haidong Dong; Dennis Wigle; Daniel H. Ahn; Chris L. Hallemeier; Shanda Blackmon; Harry H. Yoon
Clin Cancer Res (2022)
Research Article June 9 2022
Updated efficacy outcomes of anti-PD-1 antibodies plus multikinase inhibitors for advanced gastric cancer patients with or without liver metastases in clinical trials
Hiroki Yukami; Akihito Kawazoe; Yi-Tzu Lin; Shohei Koyama; Shota Fukuoka; Hiroki Hara; Naoki Takahashi; Takashi Kojima; Masako Asayama; Takako Yoshii; Hideaki Bando; Daisuke Kotani; Yoshiaki Nakamura; Yasutoshi Kuboki; Saori Mishima; Masashi Wakabayashi; Takeshi Kuwata; Masahiro Goto; Kazuhide Higuchi; Takayuki Yoshino; Toshihiko Doi; Hiroyoshi Nishikawa; Kohei Shitara
Clin Cancer Res clincanres.0630.2022-2-27 11:45:33.693.
Research Article June 9 2022
Deuterium metabolic imaging reports on TERT expression and early response to therapy in cancer
Georgios Batsios; Celine Taglang; Meryssa Tran; Nicholas Stevers; Carter Barger; Anne Marie Gillespie; Sabrina M. Ronen; Joseph F. Costello; Pavithra Viswanath
Clin Cancer Res clincanres.CCR-21-4418-A.2021.
Research Article June 8 2022
Phase II study of TQB2450, a novel PD-L1 antibody, in combination with anlotinib in patients with locally advanced or metastatic soft tissue sarcoma
Jiayong Liu; Tian Gao; Zhichao Tan; Shu Li; Jie Xu; Chujie Bai; Ruifeng Xue; Lu Xie; Lu Zhang; Zhengfu Fan; Wei Guo
Clin Cancer Res clincanres.0871.2022-3-18 10:13:03.583.
Advertisement
